Specialty Generics Market
According to Intent Market Research, the Specialty Generics Market is expected to grow from USD 1.0 Billion in 2024-e at a CAGR of 6.8% to touch USD 1.5 Billion by 2030. The Specialty Generics Market is dominated by key players such as, Teva Pharmaceuticals, Sandoz (Novartis), Mylan N.V., Cipla, Sun Pharmaceuticals, and Aurobindo Pharma.